Abstract
The spread of drug resistant microbes is a global public health challenge, which impairs the efficacy of antimicrobial agents and causes substantial increase in morbidity and mortality rates and also healthcareassociated costs. [1] [2] [3] [4] The impact of this problem is emphasized in low-resource countries because of the high prevalence of bacterial infections and the major role of antimicrobial agents in combating infectious diseases. 1, [4] [5] [6] To prevent the emergence of resistance, it is important to monitor antimicrobial drug resistance from periodically documented local microbial epidemiology and resistance rate studies.
Multiple mechanisms have been pronounced in explaining antimicrobial agent resistance. These mechanisms include enzymatic inhibition of drugs, alteration of proteins targeted by antibiotics, changes in metabolic pathways, antibiotic efflux, alterations in porin channels, and changes in membrane permeability. 7 
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Bacterial resistance to cephalosporins generally arises from the production of -lactamases, enzymes that hydrolyze the -lactam ring. Resistance can also be achieved by reduced cell wall penetrability and/or altered penicillin binding proteins (PBPs). 8 The objective of this study is to report patterns of bacterial resistance against ceftriaxone in the past 4 years (2002 to 2005) from our laboratory that will be useful in for further evaluation on the wide range of ceftriaxone use (including respiratory tract infections, uncomplicated urinary tract infection, bacterial meningitis in children, bone, skin and soft tissue infections, bacterial septicemia, intra-abdominal infections, acute bacterial otitis media and for surgical prophylaxis). Data collected were microbial species and ceftriaxone resistance profile. Microbial species were determined from culture and identification tests. The isolated species were screened for anti-microbial resistance profile using the disc diffusion method according to the methods recommended by the National Committee for Clinical Laboratory Standards Guidelines (NCCLS). [10] [11] [12] Sensitivity data were recorded quantitatively by measuring the diameters to the nearest whole millimeter. Following the interpretative chat of the Kirby-Bauer Sensitivity Test Method, the zones were interpreted as resistant, intermediate or sensitive.
The species grew from each specimens and ceftriaxon resistance profile of each specimens were noted. The data were tabulated according to the species, number of specimens and resistance rate per year.
RESULTS
There were 14 Gram negative and 7 Gram positive bacteria collected from specimens used for sensitivity testing to ceftriaxone. 
DISCUSSION
There are some limitation that must be considered in the interpreting of our findings, among others, our study derived from data during the period of 2002-2005 in a Microbiology Laboratory and we have no data on duration and result of the ceftriaxone treatment.
Infection is one of the main problems in Indonesia, and the world in general, and is associated with significant morbidity and mortality. Infections caused by bacteria should be treated by antibiotics, also known as antimicrobial drugs. 13 Obviously, if a bacterial pathogen is able to develop or acquire resistance to an antibiotic, then the antibiotic becomes useless in the treatment of infectious disease. So as pathogens develop resistance, new (different) antibiotics must be discovered to replace the useless ones in the treatment regimens. The problem is not only in finding new antibiotics to fight old diseases (because resistant strains of bacteria have emerged), but also in finding new antibiotics to fight new diseases.
As a consequence of these problems, smart use of antibiotics is the key to control the emergence of resistance. Therefore guidelines for wise antibiotics usage should be available. Monitoring of antimicrobial drug resistance using by reported data on the patterns of bacterial resistance against antimicrobial drugs is useful in preventing the emergence of resistance.
Ceftriaxone is a broad-spectrum cephalosporin, with prolonged pharmacokinetics enabling once daily dosing for intravenous or intramuscular administration. Launched in 1982, this agent has proved highly successful for the treatment of a wide range of indications, including respiratory tract infections, uncomplicated urinary tract infection, bacterial meningitis in children, Lyme disease, bone, skin and soft tissue infections, bacterial septicemia, intra-abdominal infections, acute bacterial otitis media and for surgical prophylaxis. Ceftriaxone is also indicated as single dose treatment of gonorrhoea and chancroid. Ceftriaxone was also demonstrated to have a modest degree (60 to 80 percent) of clinical efficacy in the treatment of acute otitis media caused by penicillinresistant S. pneumoniae. 15 The centers for disease control and prevention (CDC) reports from the drugresistant S. pneumoniae therapeutic working group have documented that intramuscular ceftriaxone was efficacious in acute otitis media treatment failures with three daily doses of high-dose amoxicillin; highdose amoxicillin-clavulanate; or cefuroxime axetil.
Our report showed similar findings with previous reports, i.e. ceftriaxone was still highly successful for the treatment of a wide range of indications, although resistance rates were increased from 2002 to 2005. To control the spread of ceftriaxone resistance, it is important to evaluate and develop guidelines on ceftriaxone usage in Indonesia.
In conclusion, smart use of antibiotics is the key to control the spread of resistance. To prevent emergence of Ceftriaxone resistance in the future, data about microbial resistance pattern of Ceftriaxone from 2002 to 2005 is important and should be used to develop guidelines or ceftriaxone usage.
